FDA sees no increased stroke risk for Pfizer/BioNTech Omicron vaccine in elderly (NYSE:PFE)

FDA Headquarters - White Oak Campus


Contradicting the CDC’s earlier findings, the FDA said Thursday that it did not observe an increased risk of stroke associated with Pfizer (NYSE: PFE)/ BioNTech (NASDAQ: BNTX) updated vaccinations for the elderly.

Earlier this month, US regulators noted that the CDC’s vaccine

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *